Update
Q1 FY 2026 results
Rossari Biotech Limited, one of India’s leading specialty chemicals manufacturer has presented it Q1 FY 2026 numbers today. Here are details –
The Company has posted revenue from operations of INR 543.72 Cr for the quarter ended 30 June 2025 as against revenue of INR 489.65 Cr same period last year, registering a growth of 11 percent Y-o-Y basis. However, on Q-o-Q basis the revenue declined by 6 percent (INR 579.5 Cr).
Total expenses of the company increased by 12 percent Y-o-Y basis (INR 499 Cr for 30 June 2025 v/s 444 Cr for 30 June 2024)
Rossari has registered Profit After Tax (PAT) of INR 33.60 Cr for the quarter ended 30 June 2025 as against Profit of INR 35 Cr for the period ended 30 June 2024, a de-growth of 4 percent Y-o-Y basis.
Managing Director Speech –
Commenting on the performance, Mr. Edward Menezes, Promoter & Executive Chairman, and Mr. Sunil Chari, Promoter & Managing Director, said –
We delivered a steady performance in Q1 FY26, with topline growth driven by strong momentum in our HPPC and AHN segments. Despite a challenging and evolving operating environment, our core businesses continued to demonstrate resilience. Though our export business was lower compared to the last quarter, it has shown healthy growth over the last year. While overall growth remained healthy, we are confident that our continued efficiency initiatives and focused efforts on optimizing the product mix will continue to drive growth over the coming quarters.
Looking ahead, we remain committed to execution excellence, customer-led innovation, and sustainable value creation. Supported by a robust balance sheet, a strong R&D foundation, and our ongoing capacity expansion initiatives, we are well-positioned to navigate near-term challenges and deliver consistent, profitable growth for all stakeholders.
Daily Chart –
The stock ended at INR 743 on Friday (July 18, 2025) and is trading 24% below its 52-week high of INR 973 on the National Stock Exchange.
Rossari is trading well above its 20 DEMA (695) and 200 DEMA (729) when looking at the daily chart.
LAST ARTICLE – Sterling and Wilson Renewable Energy
23 July 2020
Update:
Rossari Biotech Listing:
Rossari Biotech Limited – one of India’s prominent specialty chemical manufacturing companies started its very first first trading day with a whopping 57.65% premium over its IPO price today.
On the National Stock Exchange, the share price traded at INR 676.75, up by INR 251.75 or 59.24% over IPO price, with volumes of 40,88,564 equity shares.
On the NSE, the stock made a high of INR 803.10 and a low of INR 664 before it ended at INR 741.65 on the National Stock Exchange, up 74.51% when the market closed.
In terms of volumes, Rossari Biotech Limited traded with 35,781,623 shares on the NSE.
Read: Finblab Valuepick Stock Escorts Limited
9 July 2020
Rossari Biotech Limited is amongst India’s leading textile and specialty chemical manufacturers – is planning to raise INR 496.25 Cr via IPO [50 Cr Fresh Issue + 446.25 Cr OFS]
Rossari Biotech: Company Profile
Rossari Biotech was founded in the year 2003 as a partnership firm in the name of Rossari Labtech by Edward Walter Menezes and Sunil Srinivasan Chari, who are both career-technocrats cumulatively having more than 45 years of experience in the specialty chemicals industry.
It was further renamed to Rossari Biotech Limited and converted into a company in the year 2009.
Rossari Biotech: Business
Rossari Biotech Ltd is one of India’s prominent specialty chemical manufacturing companies and provides customized solutions to specific industrial and production requirements of its customers.
The business of the company can be classified into 3 main categories –
- home, personal care, and performance chemicals;
- textile specialty chemicals; and
- animal health and nutrition products
As per the F&S Report published on 30th Sept 2019, it is the largest textile specialty chemical manufacturer in India.
As of 31 January 2020, Rossari Biotech Limited had a range of 1,960 different products across 3 categories.
Rossari Biotech: Manufacturing Facilities
Most of the products of the company are manufactured in-house.
The Company has a manufacturing unit located at Silvassa, Dadra & Nagar Haveli with an installed capacity of 100,000 MTPA.
The company is also setting up a manufacturing unit at Dahej (Gujarat) will be commissioned in fiscal 2021 with an installed capacity of 132,500 MTPA.
Rossari Biotech: R&D facilities
Rossari Biotech also has 2 R&D facilities, one in Silvassa and second in Mumbai to focus on new product development, formulations, and cost competitiveness.
Company Strength:
The Company has more than 194 distributors across India and 27 distributors spread in other 17 countries.
Rossari: Competitive Strengths
- Diversified product portfolio addressing the needs of varied customers
- Largest textile specialty chemical manufacturer in India
- Extensive manufacturing and technical capabilities
- Solid R&D skills with a focus on innovation and sustainability
- Wide sales and distribution network
- Experienced Promoters with a strong management team
Company Promoters:
Mr. Edward Menezes is the Executive Chairman and Co-Founder of the Company and mentors the Company’s technical, manufacturing, and marketing initiatives. He comes with a vast breadth of experience spread over 34 years of having worked in textile processing in mills.
Mr. Sunil Chari is the MD and Co-Founder who drives the growth of Rossari Biotech. His passion for the (1) business, (2) people, and (3) processes provides Rossari Biotech a competitive advantage in the market. With over 30 years of experience in textiles and ancillary chemicals, Mr. Chari brings to the table his vast knowledge and market wisdom.
IPO Opening / Closing Date
IPO Details – Price, Minimum Bid and Other
Financial Performance
CONCLUSION
Considering company’s valuation, financial parameters, and the sector potential, FinBlab recommends SUBSCRIBE ratings on Rossari Biotech Limited IPO
Must Read
Value Pick Stock of the Month: Coromandel International Limited
Disclaimer: The contents and data presented here are just for your information & personal use only. While much effort is made to provide the information, I ( Vishal Dalwadi ) or “FinBlab” do not guarantee the accuracy, correctness, completeness or reliability of any information or data displayed herein and shall not be held responsible.